Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdul J Sankoh

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|April 15, 2008
A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trialAbdul J Sankoh
Statistics in Medicine|July 19, 2012
Extension of adaptive alpha allocation methods for strong control of the family-wise error rateHaihong Li, Abdul J Sankoh, Ralph B D'Agostino
Statistics in Medicine|May 17, 2014
Use of composite endpoints in clinical trialsAbdul J Sankoh, Haihong Li, Ralph B D'Agostino
Statistics in Medicine|July 5, 2017
Composite and multicomponent end points in clinical trialsAbdul J Sankoh, Haihong Li, Ralph B D'Agostino
Journal of Biopharmaceutical Statistics|October 22, 2013
Evaluation of overall treatment effect in MMRMTao Song, Qunming Dong, Abdul J Sankoh, et al.
Statistics in Medicine|October 1, 2003
Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issuesAbdul J Sankoh, Ralph B D'Agostino, Mohammad F Huque
Journal of Biopharmaceutical Statistics|February 26, 2010
An overview of practical approaches for handling missing data in clinical trialsCynthia M DeSouza, Anna T R Legedza, Abdul J Sankoh
Biopharmaceutics & Drug Disposition|November 2, 2004
The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochlorideRajesh Krishna, Sriram Krishnaswami, Barbara Kittner, et al.
The Journal of Clinical Psychiatry|February 22, 2023
Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialAnita H Clayton, Robert Lasser, Indrani Nandy, et al.
Clinical Pharmacokinetics|July 25, 2019
SAGE-217, A Novel GABA<sub>A</sub> Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding StudiesEthan Hoffmann, George G Nomikos, Inder Kaul, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|April 15, 2008
A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trialAbdul J Sankoh
Statistics in Medicine|July 19, 2012
Extension of adaptive alpha allocation methods for strong control of the family-wise error rateHaihong Li, Abdul J Sankoh, Ralph B D'Agostino
Statistics in Medicine|May 17, 2014
Use of composite endpoints in clinical trialsAbdul J Sankoh, Haihong Li, Ralph B D'Agostino
Statistics in Medicine|July 5, 2017
Composite and multicomponent end points in clinical trialsAbdul J Sankoh, Haihong Li, Ralph B D'Agostino
Journal of Biopharmaceutical Statistics|October 22, 2013
Evaluation of overall treatment effect in MMRMTao Song, Qunming Dong, Abdul J Sankoh, et al.
Statistics in Medicine|October 1, 2003
Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issuesAbdul J Sankoh, Ralph B D'Agostino, Mohammad F Huque
Journal of Biopharmaceutical Statistics|February 26, 2010
An overview of practical approaches for handling missing data in clinical trialsCynthia M DeSouza, Anna T R Legedza, Abdul J Sankoh
Biopharmaceutics & Drug Disposition|November 2, 2004
The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochlorideRajesh Krishna, Sriram Krishnaswami, Barbara Kittner, et al.
The Journal of Clinical Psychiatry|February 22, 2023
Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialAnita H Clayton, Robert Lasser, Indrani Nandy, et al.
Clinical Pharmacokinetics|July 25, 2019
SAGE-217, A Novel GABA<sub>A</sub> Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding StudiesEthan Hoffmann, George G Nomikos, Inder Kaul, et al.
Pageof 2